Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is genetically variable, allowing it to adapt to various hosts including humans. Indeed, SARS-CoV-2 has accumulated around two mutations per genome each month. The first relevant event in this context was the occurrence of the mutant D...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaqroun, Ahlam, Hartard, Cédric, Schvoerer, Evelyne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234553/
https://www.ncbi.nlm.nih.gov/pubmed/34207378
http://dx.doi.org/10.3390/v13061171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234553/
https://www.ncbi.nlm.nih.gov/pubmed/34207378
http://dx.doi.org/10.3390/v13061171

Ejemplares similares